Assessment of HER2 status from an epidemiology study in tumor tissue samples of gastric and gastro-esophageal junction cancer: Spanish results of the HER-EAGLE study.
Lourdes Gómez(Hospital Universitario Virgen del Rocío), F Vilardell(Johns Hopkins University), Juan Parra(Roche (Spain)), Maria del Pino Florez(Hospital Doctor José Molina Orosa), Tomás García‐Caballero(Universidade de Santiago de Compostela), Eva Musulén(Hospital Virgen de la Salud), Carmen Martı́nez(Hospital Universitario Virgen Macarena), Isabel Peligros(Hospital General Universitario Gregorio Marañón), Paola Beatriz Leon(Roche (Spain)), Stefania Landolfi(Universitat Autònoma de Barcelona), Joaquín González‐Carreró(University Hospital Complex Of Vigo), Mar Iglesias(Hospital Del Mar), Irune Ruiz(Biogipuzkoa Health Research Institute), Rufo Rodríguez(Hospital General Universitario Gregorio Marañón), Ángel Concha(Hospital Universitario Virgen de las Nieves), Rosa Maria Ortiz Duran(University Hospital Complex Of Vigo), Emilio Burgos(Hospital Universitario Infanta Sofía), José Ibáñez Martínez(Hospital Universitario Virgen Macarena), José Ignacio Busteros(Hospital Universitario Príncipe de Asturias)
Cited by 2
Related Papers
Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer
|Science|2017|1.6k
European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations
|United European Gastroenterology Journal|2020|219
Immunophenotypic Characterization and Quantification of the Epithelial Inflammatory Infiltrate in Eosinophilic Esophagitis Through Stereology
|The American Journal of Surgical Pathology|2007|159
TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence
|Journal of Clinical Investigation|2018|108